Trial record 1 of 12081 for:    United Therapeutics cell
Previous Study | Return to List | Next Study

Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by United Therapeutics
Sponsor:
Information provided by (Responsible Party):
United Therapeutics
ClinicalTrials.gov Identifier:
NCT01795950
First received: February 12, 2013
Last updated: January 8, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2016
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)